Corteva, Inc. (LON:0A1W)
55.07
+0.57 (1.05%)
At close: Nov 5, 2025
Corteva Revenue
Corteva had revenue of $2.62B USD in the quarter ending September 30, 2025, with 12.55% growth. This brings the company's revenue in the last twelve months to $17.47B, up 5.00% year-over-year. In the year 2024, Corteva had annual revenue of $16.91B, down -1.85%.
Revenue (ttm)
$17.47B
Revenue Growth
+5.00%
P/S Ratio
2.53
Revenue / Employee
$794.05K
Employees
22,000
Market Cap
32.92B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.91B | -318.00M | -1.85% |
| Dec 31, 2023 | 17.23B | -229.00M | -1.31% |
| Dec 31, 2022 | 17.46B | 1.80B | 11.50% |
| Dec 31, 2021 | 15.66B | 1.44B | 10.11% |
| Dec 31, 2020 | 14.22B | 371.00M | 2.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |